Breast Cancer Research and Treatment

, Volume 10, Issue 3, pp 267–272 | Cite as

Oestrogen receptor activity in breast cancer detected at a prevalence screening examination

  • M. M. Roberts
  • R. A. Hawkins
  • F. E. Alexander
  • T. J. Anderson
  • R. J. C. Steele
Report

Summary

In view of the possible introduction of screening programmes, this study compares oestrogen receptor (ER) levels in a series of women whose primary tumour was detected by screening and an age-matched consecutive series of women whose tumours were diagnosed after symptomatic presentation. Because of missing data and other statistical considerations, the comparison was made using T1 and T2 categories of tumour only. Some differences were found: the distribution of ER levels was significantly different in the two groups, with more extreme values in the symptomatic series; the screening series, however, had more moderate/rich ER levels than the symptomatic group. Tumours of special pathological type (for example, tubular, cribriform, lobular, medullary, and mucoid) were more likely to be ER-moderate or -rich, and there were more of these tumours in the screening series. The relationship of these findings to tumour growth rate is discussed. The study highlights the difficulty of obtaining sufficient tissue for conventional DCC biochemical assays from the small non-invasive tumours found by screening, and suggests that newer alternative methods employing monoclonal antibodies may be required for such types of tumour.

Key words

breast cancer oestrogen receptor pathological type screening 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hawkins RA, Roberts MM, Forrest APM: Oestrogen receptors and breast cancer: current status. Brit J Surg 67: 153–169, 1980PubMedGoogle Scholar
  2. 2.
    Rosen P, Menendez-Botet CJ, Nisselbaum JS, Urban JA, Mike V, Fracchia A, Schwartz MK: Pathological review of breast lesions analysed for oestrogen receptor protein. Cancer Research 35: 3187–3194, 1975PubMedGoogle Scholar
  3. 3.
    Maynard PV, Davies CJ, Blamey RW, Elston CW, Johnston J, Griffiths K: Relationship between oestrogen receptor content and histological grade in human primary breast tumours. Brit J Cancer 38: 745–748, 1978PubMedGoogle Scholar
  4. 4.
    Adami HO, Graffman S, Lindgren A, Sallstrom J: Prognostic implications of oestrogen receptor content in breast cancer. Breast Cancer Res Treat 5: 293–300, 1985PubMedGoogle Scholar
  5. 5.
    Bridges KG, Keshgegian AA, Mohan Kumar HA, Neal HS: Influence of surgical techniques on oestrogen and progesterone receptor determinations in breast cancer. Cancer 51: 2319–2320, 1983Google Scholar
  6. 6.
    King RJB, Barnes DM, Hawkins RA, Leake RE, Maynard PV, Roberts MM: Measurement of oestradiol receptors by five institutions on common tissue samples. Brit J Cancer 38: 428–430, 1978PubMedGoogle Scholar
  7. 7.
    Chetty U, Kirkpatrick AE, Anderson TJ, Lamb J, Roberts MM, Humeniuk V, Forrest APM: Localisation and excision of occult breast lesions. Brit J Surg 70: 607–610, 1983PubMedGoogle Scholar
  8. 8.
    Roberts MM, Alexander FE, Anderson TJ, Forrest APM, Hepburn W, Huggins A, Kirkpatrick AE, Lamb J, Lutz W, Muir BB: The Edinburgh randomised trial of screening for breast cancer: description of method. Brit J Cancer 50: 1–6, 1984PubMedGoogle Scholar
  9. 9.
    Hawkins RA, Black R, Steel RJC, Dixon JM, Forrest APM: Oestrogen receptor concentrations in primary breast cancer and axillary node metastases. Breast Cancer Res Treat 1: 245–281, 1981PubMedGoogle Scholar
  10. 10.
    Scatchard G: The attractions of protein for small molecules and ions. Ann N Y Acad Sci 51: 660–672, 1949Google Scholar
  11. 11.
    Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein, utilising the principles of protein dye binding. Analyt Biochem 72: 660–672, 1976Google Scholar
  12. 12.
    Roberts MM, Rubens RD, King RJB, Hawkins RA, Millis R, Hayward JL, Forrest APM: Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. Brit J Cancer 38: 431–436, 1978PubMedGoogle Scholar
  13. 13.
    Anderson TJ, Lamb J, Alexander FE, Roberts MM, Chetty U, Forrest APM, Huggins A, Kirkpatrick AE, Lutz W, Muir BB: Comparative pathology of prevalent and incident cancers detected by screening. Lancet (i) 519–523, 1986Google Scholar
  14. 14.
    Fisher ER, Gregoris RM, Fisher B: The pathology of invasive breast cancer. Cancer 36: 1–85, 1975PubMedGoogle Scholar
  15. 15.
    Azzopardi JG: Problems in breast pathology. In: Bennington JL (ed) Major Problems in Pathology Vol. II London, WB Saunders, 1979Google Scholar
  16. 16.
    Holdaway IM, Mountjoy KG: Progesterone and oestrogen receptors in human breast cancer. Aust NZ J Med 8: 630–638, 1978Google Scholar
  17. 17.
    Begg CB, Greenes RA: Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 39: 207–215, 1983PubMedGoogle Scholar
  18. 18.
    Dixon JM, Page DL, Anderson TJ, Lee D, Elton RA, Stewart HJ, Forrest APM: Long term survivors after breast cancer. Brit J Surg 72: 445–448, 1985PubMedGoogle Scholar
  19. 19.
    Meyer JS: Cell kinetic analysis of human breast carcinoma. In: RW McDivitt, HA Oberman, L Ozello and N Kaufmann (eds) The Breast. IAP Monographs in Pathology No. 25. Williams and Wilkins, Baltimore and London, 1984, pp 45–48Google Scholar
  20. 20.
    Cole P, Morrison A: Basic issues in population screening for cancer. J Natl Cancer Inst 64: 1263–1272, 1980PubMedGoogle Scholar
  21. 21.
    Simon R: Length biased sampling in etiologic studies. Amer J Epidemiol III: 444–453, 1980Google Scholar
  22. 22.
    King WJ, De Sombre ER, Jensen EV, Greene GL: Comparison of immunocytochemical and steroid binding assays for oestrogen receptor in human breast tumours. Cancer Res 45: 293–304, 1985PubMedGoogle Scholar
  23. 23.
    Hawkins RA, Sangster K, Krajewski A: Histochemical detection of oestrogen receptors in breast carcinoma: a successful technique. Brit J Cancer 53: 407–410, 1986PubMedGoogle Scholar
  24. 24.
    Hawkins RA, Going J, Teasdale A, Ferguson WA: Oestrogen receptor activity in intraduct and invasive breast carcinoma. Breast Cancer Res Treat. 1987, in pressGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers 1987

Authors and Affiliations

  • M. M. Roberts
    • 1
    • 2
  • R. A. Hawkins
    • 1
  • F. E. Alexander
    • 3
  • T. J. Anderson
    • 4
  • R. J. C. Steele
    • 1
  1. 1.Department of Clinical SurgeryUniversity of EdinburghUK
  2. 2.Clinical DirectorEdinburgh Breast Screening ClinicUK
  3. 3.Medical Statistics UnitUniversity of EdinburghUK
  4. 4.Department of PathologyUniversity of EdinburghUK

Personalised recommendations